Status:
COMPLETED
Platelet-Rich Plasma in the Treatment of Patients With Idiopathic Carpal Tunnel Syndrome
Lead Sponsor:
Mansoura University
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a randomized controlled trial in a cohort of Egyptian patients suffered from mild to moderate idiopathic carpal tunnel. They were randomly divided into two groups. Group 1: patients received u...
Detailed Description
Intervention: PRP Injection Group(PRP-inj-G) - This group included 49 patients (40 females and 9 males). Their age ranged from 20 to 60 years. PRP Preparation: 16 ml of blood was obtained from each ...
Eligibility Criteria
Inclusion
- Patients with mild-to-moderate idiopathic CTS with clinical manifestations failed to respond to conservative treatment ( such as splint, medications, Physical therapy) for at least 3 months and they were diagnosed by electrophysiological study and musculoskeletal ultrasound.
Exclusion
- Diabetes
- Hypothyroidism
- Rheumatoid arthritis
- Previous carpal tunnel decompressive surgery
- Cervical radiculopathy, polyneuropathy, brachial plexopathy, traumatic nerve injury, thoracic outlet syndrome
- Previous corticosteroid injection into the carpal tunnel in the preceding 4 weeks
- Anemia (hemoglobin \<10gm%)
- Coagulopathy
- Pregnancy
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03863873
Start Date
July 1 2017
End Date
January 1 2020
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University
Al Mansurah, Egypt, 35516